title: [Progression of refractory thrombocytopenia to chronic myelomonocytic leukemia accompanied by various inflammatory reactions].
abstract: A 51-year-old man was admitted for treatment of severe thrombocytopenia in May 1997. A diagnosis of MDS RA (refractory thrombocytopenia; RTC) was made by bone marrow examination, which revealed mild marrow hypoplasia and a reduced number of megakaryocytes accompanied by micromegakaryocytes and hypolobular megakaryocytes. Chromosome analysis demonstrated 46, XY, t(5;7) (q31;q22) in all 20 cells examined. The patient received only supportive therapy including platelet transfusion, until leukocytosis and monocytosis gradually developed in November 1998. In view of a marked increase in the number of monocytes (more than 3,000/microliter), a diagnosis of CMML was made in December 1998. As the leukocytosis progressed, various inflammatory symptoms such as facial erythema and endophthalmitis developed. Administration of interferon alpha (IFN alpha) unexpectedly worsened the leukocytosis and monocytosis, suggesting abnormal responses of these cells to IFN alpha. Detailed molecular analysis of these cells might reveal a novel mechanism of leukemogenesis associated with 5q31.
authors.affiliation: Department of Medicine, Hyogo Medical Center for Adults.
authors.forename: H
authors.initials: H
authors.lastname: Gomyo
authors.forename: T
authors.initials: T
authors.lastname: Murayama
authors.forename: J
authors.initials: J
authors.lastname: Kohfuku
authors.forename: I
authors.initials: I
authors.lastname: Mizuno
authors.forename: K
authors.initials: K
authors.lastname: Kajimoto
authors.forename: T
authors.initials: T
authors.lastname: Koizumi
authors.forename: S
authors.initials: S
authors.lastname: Imoto
mesh_terms: D018450:Disease Progression; D009877:Endophthalmitis / Q000209:etiology; D004890:Erythema / Q000209:etiology; D006801:Humans; D015477:Leukemia, Myelomonocytic, Chronic / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D013921:Thrombocytopenia / Q000150:complications*